PROTALIX BIOTHERAPEUTICS Stock Quote

$0.445 arrow  Change: -0.01 %Chge: -1.13% Vol: 9,522
End Of Day Prices
High: 0.4599 | Low: 0.4419 | Open: 0.4484 | Close: 0.445
52 Wk High: 0.8988 | 52 Wk Low: 0.3955 | Todays Pivot: 0.45
Sector: add stock to watch list

PLX Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Protalix Biotherapeutics

PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference

Aspertec 325 mg is an FDA-approved aspirin product being developed to provide high-risk cardiovascular and stroke patients with more reliable and predictable antiplatelet efficacy as compared to enteric-coated aspirin, while also reducing the adverse ...


Pluristem's PLX-PAD cells successful in mid-stage IC study; shares ahead 14% premarket

Pluristem Therapeutics (NASDAQ:PSTI) is up 14% premarket on robust volume in response to its announcement of positive results from a Phase 2 clinical trial assessing its PLX-PAD cells in patients with a type of peripheral arterial disease called ...


Reaffirmed: Protalix Biotherapeutics (AMEX:PLX) “Buy” Rating Maintained at H.C. Wainwright; $5.0000 Target in Place

They currently have a $5.0000 price target on Protalix Biotherapeutics (AMEX:PLX). The target price by H.C. Wainwright would suggest a potential upside of 963.83 % from the company’s last stock price. This has been disclosed in a note on 11 June.


Protalix BioTherapeutics (PLX) Announces Additional Positive Results from Final Analysis of Phase II Clinical Trial of OPRX-106 for Treatment of UC

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), announced today that additional positive results from the Company’s phase II ...


Protalix Biotherapeutics Inc (de) (NYSEAMERICAN:PLX) Can’t Be More Risky. Short Interest Increased

The stock of Protalix Biotherapeutics Inc (de) (NYSEAMERICAN:PLX) registered an increase of 2.4% in short interest. PLX’s total short interest was 5.33 million shares in June as published by FINRA. Its up 2.4% from 5.21 million shares, reported previously.



Want To Add This Quote To Your Site?

With our stock widgets you can add a Protalix Biotherapeutics quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for PLX to choose from. Visit here to build your stock quote widget »